3. Aalto TJ, Malmivaara A, Kovacs F, et al. Preoperative predictors for postoperative clinical outcome in lumbar spinal stenosis: systematic review. Spine (Phila Pa 1976) 2006;31:E648–63.
4. Richards JS, Bombardier CH, Wilson CS, et al. Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial. Arch Phys Med Rehabil 2015;96:680–9.
6. Elsamadicy AA, Adogwa O, Cheng J, Bagley C. Pretreatment of depression before cervical spine surgery improves patients’ perception of postoperative health status: a retrospective, single institutional experience. World Neurosurg 2016;87:214–9.
7. Elsamadicy AA, Adogwa O, Lydon E, et al. Depression as an independent predictor of postoperative delirium in spine deformity patients undergoing elective spine surgery. J Neurosurg Spine 2017;27:209–14.
10. Cardenas DD, Warms CA, Turner JA, Marshall H, Brooke MM, Loeser JD. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain 2002;96:365–73.
12. Fann JR, Bombardier CH, Richards JS, et al. Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial. JAMA Psychiatry 2015;72:247–58.
13. Farrokhi MR, Lotfi M, Masoudi MS, Gholami M. Effects of methylene blue on postoperative low-back pain and functional outcomes after lumbar open discectomy: a triple-blind, randomized placebocontrolled trial. J Neurosurg Spine 2016;24:7–15.
14. Kumar K, North R, Taylor R, et al. Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS Study). Neuromodulation 2005;8:213–8.
15. Thomson S, Jacques L. Demographic characteristics of patients with severe neuropathic pain secondary to failed back surgery syndrome. Pain Pract 2009;9:206–15.
16. Farrokhi MR, Yazdanpanah H, Gholami M, Farrokhi F, Mesbahi AR. Pain and functional improvement effects of methylene blue injection on the soft tissue around fusion site after traumatic thoracolumbar fixation: a double-blind, randomized placebo-controlled study. Clin Neurol Neurosurg 2016;150:6–12.
17. Rauma PH, Pasco JA, Berk M, et al. The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men. J Musculoskelet Neuronal Interact 2015;15:177–85.
18. Walid MS, Zaytseva NV. Prevalence of mood-altering and opioid medication use among spine surgery candidates and relationship with hospital cost. J Clin Neurosci 2010;17:597–600.
20. Sayadipour A, Kepler CK, Mago R, et al. Economic effects of anti-depressant usage on elective lumbar fusion surgery. Arch Bone Jt Surg 2016;4:231–5.
21. Saraykar S, John V, Cao B, Hnatow M, Ambrose CG, Rianon N. Association of selective serotonin reuptake inhibitors and bone mineral density in elderly women. J Clin Densitom 2018;21:193–9.
22. Sajan F, Conte JV, Tamargo RJ, Riley LH, Rock P, Faraday N. Association of selective serotonin reuptake inhibitors with transfusion in surgical patients. Anesth Analg 2016;123:21–8.
23. Bayoumi AB, Efe IE, Ozturk OC, et al. Antidepressant prescriptions in neurosurgical practice: a survey of current trends. Turk Neurosurg 2019;29:289–96.
24. Masedo AI, Hanley M, Jensen MP, Ehde D, Cardenas DD. Reliability and validity of a self-report FIM (FIM-SR) in persons with amputation or spinal cord injury and chronic pain. Am J Phys Med Rehabil 2005;84:167–76.
26. Attal N, Mazaltarine G, Perrouin-Verbe B, Albert T, SOFMER French Society for Physical Medicine and Rehabilitation. Chronic neuropathic pain management in spinal cord injury patients: what is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous). Ann Phys Rehabil Med 2009;52:124–41.
27. Vranken JH. Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem 2012;12:304–14.
28. van Haelst IM, Egberts TC, Doodeman HJ, et al. Use of serotonergic antidepressants and bleeding risk in orthopedic patients. Anesthesiology 2010;112:631–6.
29. Jeong BO, Kim SW, Kim SY, Kim JM, Shin IS, Yoon JS. Use of serotonergic antidepressants and bleeding risk in patients undergoing surgery. Psychosomatics 2014;55:213–20.
30. Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ. The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res 2000;34:3–10.
31. Entsuah R, Shaffer M, Zhang J. A critical examination of the sensitivity of unidimensional subscales derived from the Hamilton Depression Rating Scale to antidepressant drug effects. J Psychiatr Res 2002;36:437–48.